StockData
Vogenx, Inc. logo

Vogenx, Inc. (VOGX) stock

VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$13.48−0.90 (-6.26%)

Close on Nov 17, 2026Market cap $200.25MP/E –Yield –

Vogenx ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Vogenx

Vogenx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vogenx figures

See a number that looks wrong?